PI3K-Akt activation has been shown to lead to excessive glucose uptake by cancer cells, increasing their dependence on aerobic glycolysis, and as a consequence increasing the availability of glycolysis intermediates required for biosynthetic pathways [15]. Here, AKT1 is linked to cancer.